ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
13 hedge funds and large institutions have $533K invested in Avenue Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$35.8K | |
| 2 | +$19K | |
| 3 | +$18.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9K |
Top Sellers
| 1 | -$55K | |
| 2 | -$38K | |
| 3 | -$20.1K | |
| 4 |
BCM
Bayesian Capital Management
Brooklyn,
New York
|
-$12.8K |
| 5 |
Morgan Stanley
New York
|
-$3.05K |